← Leaderboards
Thomas D Boyer
Emory University
$2,637,621
Attributed
$2,637,621
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$2,637,621 · 3
By mechanism
M01$2,637,621 · 3
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Stephanie L. Sherman$20,101,730
- Harold M. McClure$3,517,681
- Thomas J. Murphy$3,100,981
- Nicola Longo$4,081,297
- James A Tumlin$1,387,334
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectHuman Therapy EvaluationArteriovenous Shunt SurgeryBiliary Tract Disorder ChemotherapyBlood Vessel DisorderCell Bank /RegistryCell LineCell TransformationCholanate CompoundCombination ChemotherapyCytotoxic T LymphocyteEpstein Barr VirusGastrointestinal HemorrhageGenetic ModelsGenetic Registry /Resource /Referral CenterHuman Genetic Material TagHuman TissueImmunosuppressiveLiver CirrhosisLymphoblastMethotrexateMolecular GeneticsNeoplasm /Cancer Genetics
Grant awards (9)
AML/ALL LEUKEMIAS &CYTOTOXIC T CELLS$293,069
M01 · FY2002 · RR
DISTAL SPLENORENAL VERSUS TRANSJUGULAR INTRAHEPATIC PORTAL SYSTEMIC SHUNT$293,069
M01 · FY2002 · RR
DISTAL SPLENORENAL VERSUS TRANSJUGULAR INTRAHEPATIC PORTAL SYSTEMIC SHUNT$293,069
M01 · FY2002 · RR
AML/ALL LEUKEMIAS &CYTOTOXIC T CELLS$293,069
M01 · FY2002 · RR
PRIMARY BILIARY CIRRHOSIS--UDCA-METHOTREXATE TREATMENT PROTOCOL$293,069
M01 · FY2002 · RR
PRIMARY BILIARY CIRRHOSIS--UDCA-METHOTREXATE TREATMENT PROTOCOL$293,069
M01 · FY2002 · RR
DISTAL SPLENORENAL VERSUS TRANSJUGULAR INTRAHEPATIC PORTAL SYSTEMIC SHUNT$293,069
M01 · FY2001 · RR
AML/ALL LEUKEMIAS &CYTOTOXIC T CELLS$293,069
M01 · FY2001 · RR
PRIMARY BILIARY CIRRHOSIS--UDCA-METHOTREXATE TREATMENT PROTOCOL$293,069
M01 · FY2001 · RR